RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.40
+0.14 (2.24%)
Aug 25, 2026, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $266.2 million as of August 25, 2026. Its market cap has decreased by -29.89% in one year.
Market Cap
266.20M
Enterprise Value
67.98M
1-Year Change
-29.89%
Ranking
Category
Stock Price
$6.40
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $266.20M, a decrease of -37.27%. That is a compound annual growth rate of -8.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 266.20M | -37.87% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mobia Medical | 353.22M |
| Viemed Healthcare | 337.08M |
| Electromed | 326.65M |
| TriSalus Life Sciences | 324.50M |
| AVITA Medical | 311.12M |
| CapsoVision | 301.28M |
| Treace Medical Concepts | 282.25M |
| Standard BioTools | 262.64M |